{"count": 34, "results": [{"_id": "37737447", "pmid": 37737447, "pmcid": "PMC10747420", "title": "New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway", "journal": "J Cell Mol Med", "authors": ["Alnaaim SA", "Al-Kuraishy HM", "Al-Gareeb AI", "Ali NH", "Alexiou A", "Papadakis M", "Saad HM", "Batiha GE"], "date": "2023-09-22T00:00:00Z", "doi": "10.1111/jcmm.17965", "meta_date_publication": "2023 Sep 22", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50281.04, "text_hl": "Nevertheless, the underlying mechanism of the anti-@<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ activity of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was not entirely clarified. ", "citations": {"NLM": "Alnaaim SA, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE. New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway J Cell Mol Med. 2023 Sep 22;():. PMID: 37737447", "BibTeX": "@article{37737447, title={New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway}, author={Alnaaim SA and Al-Kuraishy HM and Al-Gareeb AI and Ali NH and Alexiou A and Papadakis M and Saad HM and Batiha GE}, journal={J Cell Mol Med}}"}}, {"_id": "37175220", "pmid": 37175220, "pmcid": "PMC10179922", "title": "Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment", "journal": "Molecules", "authors": ["Pieróg M", "Socała K", "Nieoczym D", "Wyska E", "Samorek-Pieróg M", "Wlaź P"], "date": "2023-04-29T00:00:00Z", "doi": "10.3390/molecules28093810", "meta_date_publication": "2023 Apr 29", "meta_volume": "28", "meta_issue": "9", "meta_pages": "", "score": 50264.58, "text_hl": "...The effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ thresholds in the i.v. ", "citations": {"NLM": "Pieróg M, Socała K, Nieoczym D, Wyska E, Samorek-Pieróg M, Wlaź P. Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment Molecules. 2023 Apr 29;28(9):. PMID: 37175220", "BibTeX": "@article{37175220, title={Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment}, author={Pieróg M and Socała K and Nieoczym D and Wyska E and Samorek-Pieróg M and Wlaź P}, journal={Molecules}, volume={28}, number={9}}"}}, {"_id": "36833359", "pmid": 36833359, "pmcid": "PMC9957184", "title": "Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review", "journal": "Genes (Basel)", "authors": ["Jurca CM", "Kozma K", "Petchesi CD", "Zaha DC", "Magyar I", "Munteanu M", "Faur L", "Jurca A", "Bembea D", "Severin E", "Jurca AD"], "date": "2023-02-08T00:00:00Z", "doi": "10.3390/genes14020433", "meta_date_publication": "2023 Feb 8", "meta_volume": "14", "meta_issue": "2", "meta_pages": "", "score": 50260.816, "text_hl": "Some studies have found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ does not reduce @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ volume or @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ frequency when compared to a placebo, while other studies have found that it does. ", "citations": {"NLM": "Jurca CM, Kozma K, Petchesi CD, Zaha DC, Magyar I, Munteanu M, Faur L, Jurca A, Bembea D, Severin E, Jurca AD. Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review Genes (Basel). 2023 Feb 8;14(2):. PMID: 36833359", "BibTeX": "@article{36833359, title={Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review}, author={Jurca CM and Kozma K and Petchesi CD and Zaha DC and Magyar I and Munteanu M and Faur L and Jurca A and Bembea D and Severin E and Jurca AD}, journal={Genes (Basel)}, volume={14}, number={2}}"}}, {"_id": "32382676", "pmid": 32382676, "pmcid": "PMC7203078", "title": "Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice", "journal": "Heliyon", "authors": ["Zeyghami MA", "Hesam E", "Khadivar P", "Hesam HK", "Ahmadnia A", "Amini A"], "date": "2020-04-09T00:00:00Z", "doi": "10.1016/j.heliyon.2020.e03761", "meta_date_publication": "2020 Apr", "meta_volume": "6", "meta_issue": "4", "meta_pages": "e03761", "score": 50259.42, "text_hl": "Recent studies have shown that statins and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may have beneficial effects on @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ through different mechanisms. ", "citations": {"NLM": "Zeyghami MA, Hesam E, Khadivar P, Hesam HK, Ahmadnia A, Amini A. Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice Heliyon. 2020 Apr;6(4):e03761. PMID: 32382676", "BibTeX": "@article{32382676, title={Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice}, author={Zeyghami MA and Hesam E and Khadivar P and Hesam HK and Ahmadnia A and Amini A}, journal={Heliyon}, volume={6}, number={4}, pages={e03761}}"}}, {"_id": "32785826", "pmid": 32785826, "title": "Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin.", "journal": "Mol Neurobiol", "authors": ["Nesci V", "Russo E", "Arcidiacono B", "Citraro R", "Tallarico M", "Constanti A", "Brunetti A", "De Sarro G", "Leo A"], "date": "2020-11-01T00:00:00Z", "doi": "10.1007/s12035-020-02062-6", "meta_date_publication": "2020 Nov", "meta_volume": "57", "meta_issue": "11", "meta_pages": "4778-4789", "score": 50257.8, "text_hl": "Metabolic Alterations Predispose to @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@Seizure@@@ Development in High-Fat Diet-Treated @SPECIES_10090 @@@Mice@@@: the Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@.", "citations": {"NLM": "Nesci V, Russo E, Arcidiacono B, Citraro R, Tallarico M, Constanti A, Brunetti A, De Sarro G, Leo A. Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin. Mol Neurobiol. 2020 Nov;57(11):4778-4789. PMID: 32785826", "BibTeX": "@article{32785826, title={Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin.}, author={Nesci V and Russo E and Arcidiacono B and Citraro R and Tallarico M and Constanti A and Brunetti A and De Sarro G and Leo A}, journal={Mol Neurobiol}, volume={57}, number={11}, pages={4778-4789}}"}}, {"_id": "38369428", "pmid": 38369428, "title": "Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency.", "journal": "Encephale", "authors": ["Laroussi S", "Bouattour N", "Daoud S", "Moalla KS", "Sakka S", "Damak M", "Farhat N", "Mhiri C"], "date": "2024-02-17T00:00:00Z", "doi": "10.1016/j.encep.2023.11.030", "meta_date_publication": "2024 Feb 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.8, "text_hl": "Reversible @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@ and @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizures@@@ due to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@vitamin B12 deficiency@@@.", "citations": {"NLM": "Laroussi S, Bouattour N, Daoud S, Moalla KS, Sakka S, Damak M, Farhat N, Mhiri C. Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency. Encephale. 2024 Feb 17;():. PMID: 38369428", "BibTeX": "@article{38369428, title={Reversible dementia and seizures due to metformin-induced vitamin B12 deficiency.}, author={Laroussi S and Bouattour N and Daoud S and Moalla KS and Sakka S and Damak M and Farhat N and Mhiri C}, journal={Encephale}}"}}, {"_id": "36116284", "pmid": 36116284, "title": "A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis.", "journal": "Seizure", "authors": ["Singh R", "Sarangi SC", "Singh S", "Tripathi M"], "date": "2022-10-01T00:00:00Z", "doi": "10.1016/j.seizure.2022.09.003", "meta_date_publication": "2022 Oct", "meta_volume": "101", "meta_issue": "", "meta_pages": "253-261", "score": 50255.004, "text_hl": "RESULTS: This review found the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in different @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ models including genetic knockout model, chemical induced, and kindling models. ", "citations": {"NLM": "Singh R, Sarangi SC, Singh S, Tripathi M. A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis. Seizure. 2022 Oct;101():253-261. PMID: 36116284", "BibTeX": "@article{36116284, title={A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis.}, author={Singh R and Sarangi SC and Singh S and Tripathi M}, journal={Seizure}, volume={101}, pages={253-261}}"}}, {"_id": "40928653", "pmid": 40928653, "title": "Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Sarangi SC", "Pattnaik SS", "Singh R", "Dash Y", "Tripathi M", "Singh S", "Khan MA"], "date": "2025-09-10T00:00:00Z", "doi": "10.1007/s00210-025-04561-6", "meta_date_publication": "2025 Sep 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50253.977, "text_hl": "Adjuvant potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with standard anti-@<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure medications@@@ in @SPECIES_9606 @@@persons@@@ with active @DISEASE_Epilepsy @DISEASE_MESH:D004827 @@@epilepsy@@@: a randomised controlled trial.", "citations": {"NLM": "Sarangi SC, Pattnaik SS, Singh R, Dash Y, Tripathi M, Singh S, Khan MA. Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial. Naunyn Schmiedebergs Arch Pharmacol. 2025 Sep 10;():. PMID: 40928653", "BibTeX": "@article{40928653, title={Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial.}, author={Sarangi SC and Pattnaik SS and Singh R and Dash Y and Tripathi M and Singh S and Khan MA}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}, {"_id": "32652135", "pmid": 32652135, "title": "Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats.", "journal": "Life Sci", "authors": ["Vazifehkhah S", "Ali MK", "Babae JF", "Hashemi P", "Alireza MS", "Nikbakht F"], "date": "2020-09-15T00:00:00Z", "doi": "10.1016/j.lfs.2020.118066", "meta_date_publication": "2020 Sep 15", "meta_volume": "257", "meta_issue": "", "meta_pages": "118066", "score": 50250.266, "text_hl": "Recently, it has been postulated that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, an old antidiabetic oral drug, has anti-@<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizure@@@ properties mostly due to its antioxidant activities. ", "citations": {"NLM": "Vazifehkhah S, Ali MK, Babae JF, Hashemi P, Alireza MS, Nikbakht F. Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats. Life Sci. 2020 Sep 15;257():118066. PMID: 32652135", "BibTeX": "@article{32652135, title={Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats.}, author={Vazifehkhah S and Ali MK and Babae JF and Hashemi P and Alireza MS and Nikbakht F}, journal={Life Sci}, volume={257}, pages={118066}}"}}, {"_id": "33290383", "pmid": 33290383, "title": "Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.", "journal": "Psychiatr Genet", "authors": ["Kopel J", "Grooms A", "Ganapathy V", "Clothier J"], "date": "2021-02-01T00:00:00Z", "doi": "10.1097/YPG.0000000000000269", "meta_date_publication": "2021 Feb 1", "meta_volume": "31", "meta_issue": "1", "meta_pages": "32-35", "score": 50249.332, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@, and starvation induce @<m>DISEASE_Seizures</m> @DISEASE_MESH:D012640 @@@seizures@@@ in a @SPECIES_9606 @@@patient@@@ with partial @DISEASE_Immunologic_Deficiency_Syndromes @DISEASE_MESH:D007153 @@@SLC13A5 deficiency@@@: a case of pharmaco-synergistic heterozygosity.", "citations": {"NLM": "Kopel J, Grooms A, Ganapathy V, Clothier J. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity. Psychiatr Genet. 2021 Feb 1;31(1):32-35. PMID: 33290383", "BibTeX": "@article{33290383, title={Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.}, author={Kopel J and Grooms A and Ganapathy V and Clothier J}, journal={Psychiatr Genet}, volume={31}, number={1}, pages={32-35}}"}}]}